Global Myocardial Infarction Therapeutics Market Size Study, by Therapeutic Class (Antiplatelet Agents, Antithrombotic Agents, Nitrates, Calcium Channel Blockers, Lipid-Lowering Agents), by Route of Administration (Oral, Intravenous, Subcutaneous, Transdermal), by Indication (ST-Elevation Myocardial Infarction (STEMI), Non-ST-Elevation Myocardial Infarction (NSTEMI), Unstable Angina), by Mechanism of Action (Platelet Aggregation Inhibitors, Thrombin Inhibitors, Anticoagulants, Calcium Channel Blockers, HMG-CoA Reductase Inhibitors) and Regional Forecasts 2024-2032
2024/10/08
4,950 USD